The extent of disclosure for corporate social responsibility in the financial reports of Jordanian pharmaceutical companies

Abstract

This study aims to identify the disclosure level of corporate social responsibility CSR in the financial reports of Jordanian pharmaceutical Public shareholding companies listed at Amman Stock Exchange (ASE), and to achieve this goal, researchers studied number of CSR elements, which can be represented in employees, society, product, power, and the environment, where the sample consisted of all (11) Jordanian pharmaceutical companies listed at ASE, which have data available in this financial market during the period (2014-2016). In order to achieve the objectives of the study, a CSR was built which consists of (26) factors, depending on a number of previous studies, laws, and annual financial reports of these companies. The study results found that overall ratio of the CSR amounted to approximately 64%, where the highest percentage of disclosure reached 69% and the lowest was 12%. The results also showed that different company size through (total assets) had nothing to do with the quality and level of CSR disclosure. The study recommended that companies should focus on their role in CSR from the inside, through the employee's element, the need to focus on elements, such as occupational safety and health insurance, and to increase employee's efficiency through training, and rehabilitation.